In the subgroup at high cardiovascular risk, effect estimates were similar (HR 0.80, 95% CI 0.71 to 0.91)
Several factors support this: More Comprehensive Fat Loss: The activation of multiple receptors means it tackles fat from several angles, leading to potentially greater and faster weight reduction
Future studies are needed to determine if there is a benefit in NASH reduction or fibrosis regression
Available at: 102 GranhallCDonsmarkMBlicherTMGolorGSndergaardFLThomsenMet al
GLP-1 suppresses gastrointestinal motility and inhibits the migrating motor complex in healthy subjects and patients with irritable bowel syndrome
In contrast, the low dose of GLP1/GIP failed to persistently improve body weight, body composition, or food intake, but significantly ameliorated glucose handling and insulin sensitivity, and reduced basal glucose levels vs